首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Chinese Herbal Medicine on Dyslipidemia: Progress and Perspective
【24h】

Chinese Herbal Medicine on Dyslipidemia: Progress and Perspective

机译:中草药血脂异常的研究进展与展望

获取原文
           

摘要

Dyslipidemia is an independent risk factor of cardiovascular diseases. The statins are a milestone in the primary and second prevention of cardiovascular diseases and significantly improved its prognosis. Along with the long-term treatment with statins in combination with other hypolipidemic drugs or alone, its safety has attracted a particular attention in clinic, such as the elevation of transaminase and rhabdomyolysis, which have raised an idea of developing the other types of lipid-lowering agents from botanic materials. Traditional Chinese medicine (TCM) has been used in clinical practice for more than 2000 years in China and showed some beneficial effects for human health and many diseases. Recently, many studies demonstrated a favorable effect of TCM for treating dyslipidemia; however, its mechanism remains unclear or totally unknown. The progress and perspective of studies on dyslipidemia with single Chinese herb and its monomers or effective extracts during the past 10 years are discussed in the present review.
机译:血脂异常是心血管疾病的独立危险因素。他汀类药物是心血管疾病一级和二级预防的里程碑,可显着改善其预后。随着他汀类药物与其他降血脂药物联合或单独长期治疗,其安全性在临床上引起了特别关注,例如转氨酶和横纹肌溶解的升高,这引发了开发其他类型脂质的想法。植物性原料的降低剂。中药(TCM)在中国的临床实践中已经使用了2000多年,对人类健康和许多疾病显示出一些有益作用。最近,许多研究表明中药对血脂异常有良好的治疗作用。但是,其机制仍不清楚或完全未知。本文综述了过去十年中单一中草药及其单体或有效提取物对血脂异常的研究进展和展望。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号